UNIVERSITY OF WASHINGTON

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1861-01-01

Employees: 10K

Market Cap: -

Website: https://www.cs.washington.edu

Clinical Trials

PrEPARE: PrEP in Pregnancy, Accelerating Reach and Efficiency

Not Applicable

Completed

Conditions: Pre-Exposure Prophylaxis
Pregnancy Related
HIV Infections

Interventions: Other: PrEP Optimization Interventions

First Posted Date: 2021-01-19

Last Posted Date: 2025-01-08

Lead Sponsor: University of Washington

Target Recruit Count: 1958

Registration Number: NCT04712994

Locations: 🇰🇪
Kendu Sub-District Hospital, Homa Bay, Kenya
🇰🇪
Ober Health Center, Homa Bay, Kenya
🇰🇪
Masogo Sub-County Hospital, Kisumu, Kenya

and more 5 locations

Implementation of Tele-Exercise for Management of Knee Osteoarthritis in Older Rural Primary Care Patients

Not Applicable

Conditions: Knee Osteoarthritis

Interventions: Behavioral: Tele-EnhanceFitness

First Posted Date: 2021-01-13

Last Posted Date: 2021-01-13

Lead Sponsor: University of Washington

Target Recruit Count: 15

Registration Number: NCT04706702

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

Hepatitis C Pharmacy-based Strategy for Injectors

Completed

Conditions: Hepatitis C

First Posted Date: 2021-01-07

Last Posted Date: 2024-06-07

Lead Sponsor: University of Washington

Target Recruit Count: 40

Registration Number: NCT04698629

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

Aftercare Focus Study (AFS): A Clinical Trial to Reduce Short-Term Suicide Risk After Hospitalization

Phase 2

Completed

Conditions: Suicidal Ideation
Suicide, Attempted
Distress, Psychological
Quality of Life

Interventions: Behavioral: Collaborative Assessment and Management of Suicidality
Behavioral: Treatment as Usual

First Posted Date: 2021-01-05

Last Posted Date: 2021-01-05

Lead Sponsor: University of Washington

Target Recruit Count: 150

Registration Number: NCT04693845

Serial FES PET/CT to Measure Hormone Expression in Patients Undergoing Endocrine Targeted Therapy

Phase 2

Active, not recruiting

Conditions: Estrogen Receptor Positive
Primary or Recurrent Breast Carcinoma
Stage IV Breast Cancer AJCC v6 and v7

Interventions: Drug: F-18 16 Alpha-Fluoroestradiol
Procedure: Positron Emission Tomography
Procedure: Computed Tomography
Drug: Fludeoxyglucose F-18
Other: Laboratory Biomarker Analysis

First Posted Date: 2020-12-31

Last Posted Date: 2024-10-21

Lead Sponsor: University of Washington

Target Recruit Count: 2

Registration Number: NCT04692103

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Apolipoprotein E (APOE) Genotype Effects on Triglycerides and Blood Flow in the Human Brain

Not Applicable

Recruiting

Conditions: Dementia
Alzheimer Disease

Interventions: Dietary Supplement: Heavy Cream

First Posted Date: 2020-12-31

Last Posted Date: 2024-05-24

Lead Sponsor: University of Washington

Target Recruit Count: 90

Registration Number: NCT04692441

Locations: 🇺🇸
University of Washington Medical Center, Seattle, Washington, United States

Cardiovascular Effects of Racemic Epinephrine Pellets

Phase 2

Completed

Conditions: Epinephrine Causing Adverse Effects in Therapeutic Use

Interventions: Drug: HemeRX epinephrine pellets

First Posted Date: 2020-12-30

Last Posted Date: 2021-05-13

Lead Sponsor: University of Washington

Target Recruit Count: 13

Registration Number: NCT04688346

Locations: 🇺🇸
UW Center for Pediatric Dentistry, Seattle, Washington, United States

Use of Audio Recordings of Self-Hypnosis and Meditation for Fatigue Management in Multiple Sclerosis

Not Applicable

Completed

Conditions: Multiple Sclerosis
Fatigue

Interventions: Behavioral: Mindfulness Meditation (MM)
Behavioral: Self-Hypnosis (HYP)

First Posted Date: 2020-12-30

Last Posted Date: 2024-05-17

Lead Sponsor: University of Washington

Target Recruit Count: 333

Registration Number: NCT04688710

Locations: 🇺🇸
UW Medicine Multiple Sclerosis Center, Seattle, Washington, United States

Early Powered Mobility for Toddlers With Cerebral Palsy Using the Permobil® Explorer Mini and a Modified Ride-On Car

Not Applicable

Completed

Conditions: Cerebral Palsy

Interventions: Device: Permobil Explorer Mini
Device: Modified Ride-On Car

First Posted Date: 2020-12-24

Last Posted Date: 2023-08-04

Lead Sponsor: University of Washington

Target Recruit Count: 24

Registration Number: NCT04684576

Locations: 🇺🇸
Oregon State University, Corvallis, Oregon, United States
🇺🇸
Grand Valley State University, Grand Rapids, Michigan, United States
🇺🇸
University of Washington, Seattle, Washington, United States

Niraparib and TSR-042 for the Treatment of BRCA-Mutated Unresectable or Metastatic Breast, Pancreas, Ovary, Fallopian Tube, or Primary Peritoneal Cancer

Phase 1

Recruiting

Conditions: Anatomic Stage III Breast Cancer AJCC v8
Anatomic Stage IV Breast Cancer AJCC v8
BRCA-Associated Malignant Neoplasm
BRCA Hereditary Ovarian Carcinoma
Metastatic BRCA Hereditary Breast Carcinoma
Metastatic Breast Carcinoma
Metastatic Fallopian Tube Carcinoma
Metastatic Malignant Solid Neoplasm
Metastatic Ovarian Carcinoma
Metastatic Pancreatic Carcinoma

Interventions: Biological: Dostarlimab
Drug: Niraparib
Procedure: Biopsy
Procedure: Biospecimen Collection
Procedure: Computed Tomography
Procedure: Magnetic Resonance Imaging

First Posted Date: 2020-12-17

Last Posted Date: 2024-11-08

Lead Sponsor: University of Washington

Target Recruit Count: 18

Registration Number: NCT04673448

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy